Triple

T1445198
Position Surface form Disambiguated ID Type / Status
Subject Federal Food, Drug, and Cosmetic Act E31160 entity
Predicate amendedBy P1121 FINISHED
Object Drug Price Competition and Patent Term Restoration Act of 1984
The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, is a U.S. law that streamlined the approval of generic drugs while providing patent term extensions to brand-name drug manufacturers to balance innovation and competition.
E165704 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Drug Price Competition and Patent Term Restoration Act of 1984 | Statement: [Federal Food, Drug, and Cosmetic Act, amendedBy, Drug Price Competition and Patent Term Restoration Act of 1984]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Drug Price Competition and Patent Term Restoration Act of 1984
Context triple: [Federal Food, Drug, and Cosmetic Act, amendedBy, Drug Price Competition and Patent Term Restoration Act of 1984]
  • A. False Claims Amendments Act of 1986
    The False Claims Amendments Act of 1986 is a major U.S. federal law that strengthened the government’s ability to combat fraud against federal programs by expanding whistleblower (qui tam) provisions and increasing penalties for false claims.
  • B. Anti-Drug Abuse Act of 1988
    The Anti-Drug Abuse Act of 1988 is a U.S. federal law that expanded the war on drugs by increasing penalties, funding enforcement and treatment programs, and establishing a coordinated national drug control strategy.
  • C. Anti-Drug Abuse Act of 1986
    The Anti-Drug Abuse Act of 1986 is a major U.S. federal law that significantly escalated the War on Drugs by establishing mandatory minimum sentences and harsher penalties for drug offenses, particularly involving crack cocaine.
  • D. Patent and Trademark Law Amendments Act
    The Patent and Trademark Law Amendments Act, commonly known as the Bayh–Dole Act, is a U.S. federal law that allows universities, small businesses, and non-profits to retain ownership of inventions developed with federal funding, thereby promoting commercialization of research.
  • E. Bayh–Dole Act
    The Bayh–Dole Act is a landmark 1980 U.S. law that allows universities, small businesses, and other institutions to retain ownership of inventions developed with federal funding, spurring technology transfer and commercialization.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Drug Price Competition and Patent Term Restoration Act of 1984
Triple: [Federal Food, Drug, and Cosmetic Act, amendedBy, Drug Price Competition and Patent Term Restoration Act of 1984]
Generated description
The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, is a U.S. law that streamlined the approval of generic drugs while providing patent term extensions to brand-name drug manufacturers to balance innovation and competition.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Drug Price Competition and Patent Term Restoration Act of 1984
Target entity description: The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, is a U.S. law that streamlined the approval of generic drugs while providing patent term extensions to brand-name drug manufacturers to balance innovation and competition.
  • A. False Claims Amendments Act of 1986
    The False Claims Amendments Act of 1986 is a major U.S. federal law that strengthened the government’s ability to combat fraud against federal programs by expanding whistleblower (qui tam) provisions and increasing penalties for false claims.
  • B. Anti-Drug Abuse Act of 1988
    The Anti-Drug Abuse Act of 1988 is a U.S. federal law that expanded the war on drugs by increasing penalties, funding enforcement and treatment programs, and establishing a coordinated national drug control strategy.
  • C. Anti-Drug Abuse Act of 1986
    The Anti-Drug Abuse Act of 1986 is a major U.S. federal law that significantly escalated the War on Drugs by establishing mandatory minimum sentences and harsher penalties for drug offenses, particularly involving crack cocaine.
  • D. Patent and Trademark Law Amendments Act
    The Patent and Trademark Law Amendments Act, commonly known as the Bayh–Dole Act, is a U.S. federal law that allows universities, small businesses, and non-profits to retain ownership of inventions developed with federal funding, thereby promoting commercialization of research.
  • E. Bayh–Dole Act
    The Bayh–Dole Act is a landmark 1980 U.S. law that allows universities, small businesses, and other institutions to retain ownership of inventions developed with federal funding, spurring technology transfer and commercialization.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a4991633388190a4d61b5a98aa407a completed March 1, 2026, 7:52 p.m.
NER Named-entity recognition batch_69a4c55714588190a95b4f677c21cbaa completed March 1, 2026, 11:01 p.m.
NED1 Entity disambiguation (via context triple) batch_69ad08c046b08190a448ba2549dc5e00 completed March 8, 2026, 5:27 a.m.
NEDg Description generation batch_69ad09ec3b388190b492e8959a3617c9 completed March 8, 2026, 5:32 a.m.
NED2 Entity disambiguation (via description) batch_69ad0aefb1c88190a368d68454a0b9d0 completed March 8, 2026, 5:36 a.m.
Created at: March 1, 2026, 8 p.m.